CDC Committee Expands Flu Vaccination Recommendation for Children

A panel of immunization experts voted yesterday to expand the recommended ages for annual influenza vaccination of children to include all children from 6 months through 18 years of age. The previous recommendation was for vaccination of children from 6 months to 59 months of age. The expanded recommendation is to take effect as soon as feasible, but no later than the 2009-2010 influenza season.

The Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on vaccine issues, voted on the new recommendation during its February 27-28, 2008 meeting in Atlanta. The new recommendation increases the number of children recommended for vaccination by approximately 30 million.

CDC says, studies have shown that healthy children bear a significant burden from influenza disease and are at increased risk of needing influenza-related medical care. In addition, there is evidence showing that reducing influenza transmission among children has the potential to reduce influenza among their household contacts and within the community.

"This new recommendation should reduce the risk of influenza infections among children of all ages, and their consequent need for medical visits and missed time from school," said Dr. Anne Schuchat, director of CDC's National Center for Immunization and Respiratory Diseases.

Full implementation by Fall 2009 at the latest will allow time to plan for the vaccination of this large group of children, CDC says. However, immunization providers are advised to begin efforts to offer influenza vaccination to all children aged 6 months through 18 years in the 2008-09 influenza season if feasible, consistent with the current recommendation that all persons who want to reduce the risk of becoming ill with influenza or of transmitting influenza to others should be vaccinated.

"This new recommendation will help parents understand that all children can benefit from vaccination and further encourages providers to start vaccination of children through age 18 next year," Schuchat said.

ACIP continues to recommend vaccination of all children who have certain chronic medical conditions such as asthma, diabetes, kidney disease, or weakened immune systems. In addition, ACIP says vaccinating children younger than 5 years old should continue to be a priority because they are at higher risk for more severe influenza complications compared to older children. Household contacts of children younger than 6 months old should be vaccinated because children younger than six months cannot be given influenza vaccine, but they are the pediatric group at highest risk of influenza complications.

The 2008-09 influenza vaccine for the United States will include three new strains: an A/Brisbane/10/2007 (H3N2)-like virus, a B/Florida/4/2006-like virus and A/Brisbane/59/2007 (H1N1)-like virus strain. The H3N2 and B virus vaccine components in the U.S. vaccine are included in the 2008 vaccine for the Southern Hemisphere. Influenza vaccine manufacturers produced as many as 130 million doses of influenza vaccine for the 2007-08 influenza season and have discussed expanding current production capacity in the coming years.

Recommendations of the ACIP become recommendations of CDC once they are accepted by the director of CDC and the Secretary of Health and Human Services and are published in the Morbidity and Mortality Weekly Report.

For more information, visit www.cdc.gov.

Product Showcase

  • SlateSafety BAND V2

    SlateSafety BAND V2

    SlateSafety's BAND V2 is the most rugged, easy-to-use connected safety wearable to help keep your workforce safe and help prevent heat stress. Worn on the upper arm, this smart PPE device works in tandem with the SlateSafety V2 system and the optional BEACON V2 environmental monitor. It includes comprehensive, enterprise-grade software that provides configurable alert thresholds, real-time alerts, data, and insights into your safety program's performance all while ensuring your data is secure and protected. Try it free for 30 days. 3

Featured

Webinars